MAR 25, 2019 9:04 AM PDT

Aspirin Combats Tuberculosis

WRITTEN BY: Nouran Amin

Tuberculosis is a global infection far from being eradicated. It currently infects more than 1,400 people per year in Australia. The deadliest form and expensive to treat is antibiotic resistant tuberculosis—costing about $250,000 to treat a single case.

Now, researchers at the Centenary Institute have been working on new treatments for tuberculosis by seeking to increase the effectiveness of the immune system. In particular, they found a brand new target for the treatment of drug-resistant tuberculosis. Through their understanding that the tuberculosis bacterium alters platelets from the body's blood clotting system to weaken the immune systems—scientists were able to use a zebrafish model of tuberculosis to observe the build-up of clots and activation of platelets on infected regions, using fluorescent microscopy.

"The zebrafish gives us literal insight into disease processes by watching cells interacting in real time,” says senior author and head of the Centenary's Immune-Vascular Interactions laboratory, Dr. Stefan Oehlers.

 

 

Green platelets sticking to red blood vessels next to sites of infection by blue bacteria. Pathogenic platelets are the green cells that stick next to the bacteria for a few minutes.

According to the study published in The Journal of Infectious Diseases, the platelets were found to be tricked by the infection by getting in to the way of the body's defense system. Therefore, they treated the sites of infection with anti-platelet drugs, including the most common form of aspirin. The aspirin was found to prevent the altercations of platelets and allowed the body to control the infection better.

"This is the first time that platelets have been found to worsen tuberculosis in an animal model. It opens up the possibility that anti-platelet drugs could be used to help the immune system fight off drug resistant TB,” says Dr. Elinor Hortle, lead author of the paper. "Our study provides more crucial evidence that widely available aspirin could be used to treat patients with severe tuberculosis infection and save lives.”

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 12, 2019
Drug Discovery & Development
DEC 12, 2019
Probiotics Treat Alcohol-Induced Liver Injury
Alcoholic liver injury is caused by overconsumption of alcohol, something that can lead to serious diseases such as liver steatosis, liver cirrhosis and li...
DEC 19, 2019
Drug Discovery & Development
DEC 19, 2019
Upcoming Psychedelic Cure for Addiction Derived from African Shrub
Every year, almost 70,000 people die from an overdose in the US. Now, a company called MindMed is testing a compound derived from ibogaine, a West African ...
JAN 09, 2020
Drug Discovery & Development
JAN 09, 2020
Can Cancer Drugs Treat Lung Damage?
Can therapeutics used in the treatment of cancer be a breakthrough for pulmonary disease? Specifically, chronic obstructive pulmonary disease (COPD)? &ldqu...
JAN 21, 2020
Cell & Molecular Biology
JAN 21, 2020
Repurposing Existing Drugs to Treat Cancer
Drugs have to be rigorously tested before they can be offered to patients, so it can be much easier to find more than one application for a medication....
FEB 02, 2020
Microbiology
FEB 02, 2020
A Potential Treatment for MERS is Found
A coronavirus causes MERS, which currently has no treatment. This work may help change that....
FEB 21, 2020
Health & Medicine
FEB 21, 2020
Frequent Cannabis Use Could Affect Driving Safety
A new study suggests that heavy marijuana users have the potential to be dangerous drivers. However, hazardous driving appears to be isolated to users who ...
Loading Comments...